Skip to main content

Menu

Select a tool from the sidebar

Create your free account now!

Sign in to customize and use tools on the sidebar.

Sign InCreate free account
Sun Pharmaceutical Industries Limited logo
SUNPHARMA.NS
Sun Pharmaceutical Industries Limited
10:00:02
1838.3 ₹
0.0000 (%0.00)
Previous Close: 1824.8
Day Low₺1820.9
Day High₺1842.7
Bid
Ask
Overview
Technicals
Financial Statements
Comments
Archive

SUNPHARMA.NS: Sun Pharmaceutical Industries Limited Financials

Sun Pharmaceutical Industries Limited Income Statement

Total revenue
Net income
Gross margin TTM
55.7%
Operating margin TTM
23.18%
Net profit margin TTM
19.64%
Return on investment TTM
13.74%
Period end31/03/202631/03/202531/03/202431/03/2023
Total revenue584,620,400,000525,784,400,000484,968,500,000438,856,800,000
Operating income135,533,700,000278,149,400,000244,244,800,000219,043,900,000
Net income114,794,200,000109,290,400,00095,763,800,00084,735,800,000

All line items

Line item31/03/202631/03/202531/03/202431/03/2023
Total revenue584,620,400,000525,784,400,000484,968,500,000438,856,800,000
Cost of revenue259,003,900,000115,584,500,000114,421,800,000113,186,700,000
Gross profit325,616,500,000410,199,900,000370,546,700,000325,670,100,000
Research and development expenses34,741,000,00031,541,900,00031,277,000,00023,077,200,000
General and administrative expenses0000
Selling and marketing expenses0000
Selling, general and administrative expenses155,341,800,000100,508,600,00095,024,900,00083,549,000,000
Other expenses0000
Operating expenses190,082,800,000132,050,500,000126,301,900,000106,626,200,000
Cost and expenses449,086,700,000247,635,000,000240,723,700,000219,812,900,000
Net interest income-3,389,100,0007,147,600,0007,844,400,0001,946,100,000
Interest income08,790,700,00010,229,100,0003,416,800,000
Interest expense3,389,100,0001,643,100,0002,384,700,0001,470,700,000
Depreciation and amortization29,378,500,00023,624,600,00023,558,500,00023,455,700,000
EBITDA183,397,700,000149,679,400,000128,760,000,000116,513,200,000
EBIT154,019,200,000126,054,800,000105,201,500,00093,057,500,000
Non-operating income (excl. interest)-18,485,500,000152,094,600,000139,043,300,000125,986,400,000
Operating income135,533,700,000278,149,400,000244,244,800,000219,043,900,000
Total other income/expenses (net)15,096,400,000-140,781,600,000-133,750,000,000-125,438,600,000
Income before tax150,630,100,000137,367,800,000110,494,800,00093,605,300,000
Income tax expense35,543,600,00027,720,300,00014,394,500,0008,475,900,000
Net income from continuing operations115,086,500,000109,647,500,00096,100,300,00085,129,400,000
Net income from discontinued operations0000
Other adjustments to net income0000
Net income114,794,200,000109,290,400,00095,763,800,00084,735,800,000
Net income deductions0000
Bottom line net income114,794,200,000109,290,400,00095,763,800,00084,735,800,000
EPS48464035
Diluted EPS48464035
Weighted average shares outstanding2,401,552,0002,396,719,0002,399,335,0002,399,335,000
Weighted average diluted shares outstanding2,401,552,0002,396,719,0002,399,335,0002,399,335,000

Sun Pharmaceutical Industries Limited Balance Sheet

Total assets
Total liabilities & equity
Liquidity ratio MRQ
—
Current ratio MRQ
—
Long-term debt / assets MRQ
0%
Total debt / assets MRQ
—
Period end31/03/202631/03/202531/03/202431/03/2023
Total assets1,087,852,200,000921,005,800,000854,628,800,000807,435,900,000
Total liabilities249,054,800,000196,146,300,000183,569,100,000214,281,200,000
Total equity835,700,900,000722,180,200,000636,667,500,000559,953,800,000

All line items

Line item31/03/202631/03/202531/03/202431/03/2023
Cash and cash equivalents116,030,800,000113,316,200,00092,856,500,00046,237,300,000
Short-term investments209,334,500,000136,561,000,00053,712,300,000105,062,800,000
Cash and short-term investments325,365,300,000249,877,200,000190,900,600,000159,074,100,000
Net receivables155,623,700,000130,461,100,000112,602,400,000114,567,900,000
Accounts receivable155,096,700,000130,461,100,000112,602,400,000114,385,100,000
Other receivables527,000,00000424,100,000
Inventory114,929,300,000102,433,300,000102,948,900,000105,130,500,000
Prepaid expenses004,135,400,0003,717,700,000
Other current assets42,684,600,00043,473,100,00023,743,800,00016,129,200,000
Total current assets638,602,900,000526,244,700,000434,331,100,000398,619,400,000
Property, plant and equipment (net)124,947,600,000112,702,800,000113,000,500,000113,537,300,000
Goodwill98,330,800,00089,394,200,00085,989,500,00087,127,100,000
Intangible assets135,461,600,00090,205,400,00086,662,600,00093,268,400,000
Goodwill and intangible assets233,792,400,000179,599,600,000172,652,100,000180,395,500,000
Long-term investments38,574,400,00046,977,000,00064,412,300,00055,470,500,000
Tax assets40,464,600,0000418,700,00031,642,400,000
Other non-current assets11,470,300,00055,481,700,00069,814,100,00027,556,800,000
Total non-current assets449,249,300,000394,761,100,000420,297,700,000408,602,500,000
Other assets000214,000,000
Total assets1,087,852,200,000921,005,800,000854,628,800,000807,435,900,000
Total payables86,838,400,00061,843,400,00060,650,000,00059,902,300,000
Accounts payable73,338,000,00061,843,400,00056,533,000,00056,815,200,000
Other payables13,500,400,00004,117,000,0003,087,100,000
Accrued expenses0016,819,700,0000
Short-term debt42,344,300,00018,671,100,00028,443,600,00061,978,800,000
Capital lease obligations (current)01,368,200,0001,256,900,0001,280,800,000
Tax payables004,117,000,0003,087,100,000
Deferred revenue001,265,400,00072,561,800,000
Other current liabilities97,037,700,000100,059,400,00061,408,400,0003,340,100,000
Total current liabilities226,220,400,000181,942,100,000169,844,000,000199,063,800,000
Long-term debt025,200,00013,300,0000
Capital lease obligations (non-current)3,616,300,0003,557,400,0003,022,900,0005,599,100,000
Deferred revenue (non-current)03,767,400,0004,893,700,0005,698,700,000
Deferred tax liabilities (non-current)3,780,200,0001,924,400,0001,718,600,000316,900,000
Other non-current liabilities15,437,900,0004,929,800,0004,250,900,0003,602,700,000
Total non-current liabilities22,834,400,00014,204,200,00013,893,100,00015,217,400,000
Other liabilities00-6,300,0000
Capital lease obligations3,616,300,0004,925,600,0004,279,800,0006,879,900,000
Total liabilities249,054,800,000196,146,300,000183,569,100,000214,281,200,000
Treasury stock0000
Preferred stock0000
Common stock2,399,300,0002,399,300,0002,399,300,0002,399,300,000
Retained earnings0578,618,400,000501,589,300,000436,102,500,000
Additional paid-in capital011,881,600,00011,874,100,00011,874,100,000
Accumulated other comprehensive income/loss0129,244,600,000120,804,800,00073,671,400,000
Other stockholders' equity835,700,900,000000
Total stockholders' equity835,700,900,000722,180,200,000636,667,500,000559,953,800,000
Total equity838,797,400,000724,859,500,000671,059,700,000593,154,700,000
Minority interest3,096,500,0002,679,300,00034,392,200,00033,200,900,000
Total liabilities and total equity1,087,852,200,000921,005,800,000854,628,800,000807,435,900,000
Total investments247,908,900,000183,538,000,000118,124,600,000160,533,300,000
Total debt45,960,600,00023,621,900,00032,736,700,00068,896,600,000
Net debt-70,070,200,000-89,694,300,000-60,119,800,00022,659,300,000

Sun Pharmaceutical Industries Limited Cash Flow Statement

Cash from operations
Cash from investing
Cash flow / share TTM
—
Revenue / share TTM
—
Operating cash flow TTM
—
Period end31/03/202631/03/202531/03/202431/03/2023
Cash from operations128,517,800,000140,720,900,000121,349,800,00049,593,300,000
Cash from investing-121,081,100,000-53,061,600,000-6,902,000,000-79,436,800,000
Cash from financing-21,810,900,000-79,058,200,000-67,101,600,00023,760,700,000
Net change in cash13,143,100,0009,831,200,00046,619,200,0001,154,800,000

All line items

Line item31/03/202631/03/202531/03/202431/03/2023
Net income114,794,200,000109,290,400,00095,763,800,00094,084,300,000
Depreciation and amortization025,753,900,00025,567,900,00025,294,300,000
Deferred income tax0000
Stock-based compensation0000
Change in working capital-12,677,900,000-3,235,600,00010,621,300,000-56,618,200,000
Accounts receivable0-16,020,500,0003,528,900,000-9,531,700,000
Inventory0-1,839,700,0005,988,100,000-12,022,000,000
Accounts payable05,279,700,0002,497,200,00011,823,700,000
Other working capital-12,677,900,0009,344,900,000-1,392,900,000-46,888,200,000
Other non-cash items26,401,500,0008,912,200,000-10,603,200,000-13,167,100,000
Net cash from operating activities128,517,800,000140,720,900,000121,349,800,00049,593,300,000
Investments in property, plant and equipment-36,093,700,000-21,285,800,000-22,018,100,000-20,855,800,000
Acquisitions (net)-33,090,100,000-2,118,200,000-2,299,100,000-46,858,200,000
Purchases of investments0-345,152,100,000-306,787,500,000-226,893,300,000
Sales/maturities of investments0306,510,600,000315,905,000,000210,457,100,000
Other investing activities-51,897,300,0008,983,900,0008,297,700,0004,713,400,000
Net cash from investing activities-121,081,100,000-53,061,600,000-6,902,000,000-79,436,800,000
Net debt issuance0-10,303,400,000-33,899,300,00051,296,600,000
Long-term net debt issuance0-11,166,500,000-35,329,400,00052,601,500,000
Short-term net debt issuance0-482,000,0001,430,100,000-1,304,900,000
Net stock issuance-38,000,000-28,998,500,000-773,900,0000
Net common stock issuance-38,000,000-28,998,500,000-773,900,0000
Common stock issuance0000
Common stock repurchased0-28,998,500,000-773,900,0000
Net preferred stock issuance0000
Net dividends paid-39,339,000,000-36,139,700,000-28,981,700,000-25,188,800,000
Common dividends paid0-36,139,700,000-28,981,700,000-25,188,800,000
Preferred dividends paid0000
Other financing activities17,566,100,000-3,616,600,000-3,446,700,000-2,347,100,000
Net cash from financing activities-21,810,900,000-79,058,200,000-67,101,600,00023,760,700,000
Effect of FX changes on cash27,517,300,0001,230,400,000-739,900,0001,570,700,000
Net change in cash13,143,100,0009,831,200,00046,619,200,0001,154,800,000
Cash at end of period116,030,800,000102,687,700,00092,856,500,00046,237,300,000
Cash at beginning of period102,887,700,00092,856,500,00046,237,300,00045,082,500,000
Operating cash flow128,517,800,000140,720,900,000121,349,800,00049,593,300,000
Capital expenditure-36,093,700,000-21,285,800,000-22,018,100,000-20,855,800,000
Free cash flow92,424,100,000119,435,100,00099,331,700,00028,737,500,000
Income taxes paid0000
Interest paid02,238,200,00000